Author Instructions: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 22: | Line 22: | ||
**Populate all the tables (i.e. for immunophenotype, chromosomal rearrangements, genomic gain/loss/LOH, etc) when applicable (DO NOT delete tables). | **Populate all the tables (i.e. for immunophenotype, chromosomal rearrangements, genomic gain/loss/LOH, etc) when applicable (DO NOT delete tables). | ||
**Insert N/A into sections or tables when there is not applicable content; for tables, delete the examples. | **Insert N/A into sections or tables when there is not applicable content; for tables, delete the examples. | ||
**Use HUGO-approved gene names and symbols (italicized when appropriate), HGVS-based nomenclature for variants, as well as generic names of drugs and testing platforms or assays if applicable | **Use [https://www.genenames.org/ HUGO-approved gene names and symbols] (italicized when appropriate), [https://varnomen.hgvs.org/ HGVS-based nomenclature for variants], as well as generic names of drugs and testing platforms or assays if applicable | ||
**The use of bullet points alongside short blocks of text rather than only large paragraphs is encouraged. | **The use of bullet points alongside short blocks of text rather than only large paragraphs is encouraged. | ||